| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Pitt Justin D | Pres,Chief Legal&Admin Officer | 4000 MERIDIAN BOULEVARD, FRANKLIN | Christopher G. Cobb, Attorney in Fact for Justin D. Pitt | 03 Mar 2026 | 0001900988 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYH | Common Stock | Options Exercise | $0 | +30,000 | +12% | $0.000000 | 272,672 | 01 Mar 2026 | Direct | F1 |
| transaction | CYH | Common Stock | Award | $0 | +40,000 | +15% | $0.000000 | 312,672 | 01 Mar 2026 | Direct | F2 |
| transaction | CYH | Common Stock | Tax liability | $86,230 | -24,922 | -8% | $3.46 | 287,750 | 01 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYH | Performance Based Restricted | Options Exercise | $0 | -30,000 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 30,000 | $0.000000 | Direct | F1 |
| transaction | CYH | Performance Based Restricted | Award | $0 | +80,000 | $0.000000 | 80,000 | 01 Mar 2026 | Common Stock | 80,000 | $0.000000 | Direct | F3 | |
| transaction | CYH | Stock Options (Right to Buy) | Award | $0 | +40,000 | $0.000000 | 40,000 | 01 Mar 2026 | Common Stock | 40,000 | $3.46 | Direct | F4 | |
| holding | CYH | Performance Based Restricted | 30,000 | 01 Mar 2026 | Common Stock | 30,000 | $0.000000 | Direct | F5 | |||||
| holding | CYH | Performanced Based Restricted | 80,000 | 01 Mar 2026 | Common Stock | 80,000 | $0.000000 | Direct | F6 | |||||
| holding | CYH | Stock Options (Right to Buy) | 5,000 | 01 Mar 2026 | Common Stock | 5,000 | $4.99 | Direct | ||||||
| holding | CYH | Stock Options (Right to Buy) | 20,000 | 01 Mar 2026 | Common Stock | 20,000 | $4.93 | Direct | ||||||
| holding | CYH | Stock Options (Right to Buy) | 20,000 | 01 Mar 2026 | Common Stock | 20,000 | $8.81 | Direct | ||||||
| holding | CYH | Stock Options (Right to Buy) | 30,000 | 01 Mar 2026 | Common Stock | 30,000 | $10.18 | Direct | ||||||
| holding | CYH | Stock Options (Right to Buy) | 30,000 | 01 Mar 2026 | Common Stock | 30,000 | $6.15 | Direct | ||||||
| holding | CYH | Stock Options (Right to Buy) | 30,000 | 01 Mar 2026 | Common Stock | 30,000 | $2.87 | Direct | F4 | |||||
| holding | CYH | Stock Options (Right to Buy) | 40,000 | 01 Mar 2026 | Common Stock | 40,000 | $3.01 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023. |
| F2 | The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. |
| F3 | The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period. |
| F4 | Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. |
| F5 | The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. |
| F6 | The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2025 and 12/31/2027 (the "2025-2027 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2025-2027 Performance Period. |